The perspective of caffeine and caffeine derived compounds in therapy

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62156489%3A43410%2F15%3A43907728" target="_blank" >RIV/62156489:43410/15:43907728 - isvavai.cz</a>

Alternative codes found

RIV/60162694:G44__/15:43875426

Result on the web

<a href="http://dx.doi.org/10.4149/BLL_2015_106" target="_blank" >http://dx.doi.org/10.4149/BLL_2015_106</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.4149/BLL_2015_106" target="_blank" >10.4149/BLL_2015_106</a>

Result language

angličtina

Original language name

The perspective of caffeine and caffeine derived compounds in therapy

Original language description

Caffeine (1,3,7-trimethylxanthine) is a plant secondary metabolite with a significant impact on multiple processes and regulatory pathways in the body. Though major part of the population meets caffeine via coffee, tea or chocolate, it has also an important role in pharmacology and it is used as a supplementary substance in medicaments. Currently, the ability of caffeine to ameliorate some neurodegenerative disorders is proved in some studies. This review describes basic data about caffeine including toxicity, pharmacokinetics, biological mechanism of the action, and metabolism. Beside this, promising applications of caffeine, new medicaments and derivatives are discussed. Relevant papers and inventions are depicted in the manuscript. Caffeine is a pharmacologically promising substance that deserves big consideration in the current research and development. The compound has several reasons to be an object of scientific interest and to be used for pharmacology purposes. Despite an exten

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FR - Pharmacology and apothecary chemistry

OECD FORD branch

—

Project

<a href="/en/project/LH11023" target="_blank" >LH11023: Improvement of vaccination efficacy by cholinergic anti-inflammatory pathway</a><br>

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2015

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Bratislavské lekárske listy: international journal for biomedical sciences and clinical medicine

ISSN

0006-9248

e-ISSN

—

Volume of the periodical

116

Issue of the periodical within the volume

9

Country of publishing house

SK - SLOVAKIA

Number of pages

11

Pages from-to

520-530

UT code for WoS article

000362801800002

EID of the result in the Scopus database

—